NASDAQ:NSPH - Nanosphere Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close$1.69
Today's Range$1.69 - $1.69
52-Week Range$0.48 - $3.64
VolumeN/A
Average Volume886,293 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Nanosphere, Inc. is engaged in developing, manufacturing and marketing an advanced molecular diagnostics platform, the Verigene System, which enables genomic and protein testing on a single platform. The Verigene System includes a molecular diagnostics workstation that is a single use consumable for testing. The Verigene System consists of a microfluidics processor, a touchscreen reader and disposable test cartridges. The Company is focused on the infectious disease diagnostics market. Its Infectious Disease Assays include Respiratory Virus with Sub-Typing (RV+); Respiratory Pathogens/Expanded Panel (RP Flex); Bloodstream Infection (BSI) Panels, which include Blood Culture – Gram Positive (BC-GP), Blood Culture – Gram Negative (BC-GN) and Blood Culture – Yeast (BC-Y); C. difficile (CDF), and Enteric Panel (EP). Its Human Pharmacogenetic Assays include Hypercoagulation (FV, FII, MTHFR Panel) and CYP2C19 Genetic Variance. It is focused on the infectious disease diagnostics market.

Receive NSPH News and Ratings via Email

Sign-up to receive the latest news and ratings for NSPH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:NSPH
CUSIPN/A
Phone+1-847-4009000

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
OptionableNot Optionable

Nanosphere (NASDAQ:NSPH) Frequently Asked Questions

What is Nanosphere's stock symbol?

Nanosphere trades on the NASDAQ under the ticker symbol "NSPH."

How were Nanosphere's earnings last quarter?

Nanosphere, Inc. (NASDAQ:NSPH) posted its quarterly earnings data on Monday, May, 16th. The medical research company reported ($0.55) EPS for the quarter, beating the Zacks' consensus estimate of ($0.59) by $0.04. The medical research company had revenue of $6.60 million for the quarter, compared to analyst estimates of $6.50 million. The company's revenue was up 43.5% compared to the same quarter last year. During the same period in the prior year, the company earned ($1.29) EPS. View Nanosphere's Earnings History.

Has Nanosphere been receiving favorable news coverage?

Media coverage about NSPH stock has trended somewhat positive on Saturday, according to InfoTrie. InfoTrie rates the sentiment of press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Nanosphere earned a media sentiment score of 1.5 on InfoTrie's scale. They also gave news articles about the medical research company a news buzz of 4.0 out of 10, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near future.

How do I buy shares of Nanosphere?

Shares of NSPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Nanosphere's official website?

The official website for Nanosphere is http://www.nanosphere.us/.

How can I contact Nanosphere?

Nanosphere's mailing address is 4088 Commercial Ave, NORTHBROOK, IL 60062-1829, United States. The medical research company can be reached via phone at +1-847-4009000.


MarketBeat Community Rating for Nanosphere (NASDAQ NSPH)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  132 (Vote Outperform)
Underperform Votes:  130 (Vote Underperform)
Total Votes:  262
MarketBeat's community ratings are surveys of what our community members think about Nanosphere and other stocks. Vote "Outperform" if you believe NSPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NSPH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel